Toggle light / dark theme

Narrated by Laurence Fishburne (The Matrix, Apocalypse Now, Batman v Superman: Dawn of Justice), Year Million brings to life the ideas and innovations that will power our evolution throughout the universe.

Each episode will follow the story of a family as they navigate through the future, one invention at a time.

National Geographic is available in the UK on Sky, Virgin Media, TalkTalk and BT. Visit natgeotv.com for exclusive videos and TV listings.

Transhumanists are redefining what it means to be human. This talk takes a deeper look at the movement and its implications for the future.
About this event.

From bionic eyes to designing new senses and extending life expectancy, transhumanists are redefining what it means to be human. This talk takes a deeper look at the movement and its implications for the future of humanity.

Transhumanism is the belief that human beings are destined to transcend their mortal flesh through technology. From bionic eyes to designing new senses and extending life expectancy, transhumanists are redefining what it means to be human.

The profiles of transhumans are as diverse as its application. From artists and CEOs to academics and bedroom hackers, the transhumanist movement raises some important questions for us all.

While we love the efficiency and connectivity technology provides, can we embrace a future where it goes beyond our environment and enters our bodies and minds? Could we reach a point where we gift friends and family cognitive implants and new senses? If we are able to defy death, what are the implications for the meaning of life? And, most importantly, will this evolution divide or unite us?

Biographies:

As part of its ongoing work to track variants, WHO’s Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) met on the 24 October 2022 to discuss the latest evidence on the Omicron variant of concern, and how its evolution is currently unfolding, in light of high levels of population immunity in many settings and country differences in the immune landscape. In particular, the public health implications of the rise of some Omicron variants, specifically XBB and its sublineages (indicated as XBB, as well as BQ.1 and its sublineages (indicated as BQ.1, were discussed. Based on currently available evidence, the TAG-VE does not feel that the overall phenotype of XBB* and BQ.1* diverge sufficiently from each other, or from other Omicron lineages with additional immune escape mutations, in terms of the necessary public health response, to warrant the designation of new variants of concern and assignment of a new label. The two sublineages remain part of Omicron, which continues to be a variant of concern. This decision will be reassessed regularly. If there is any significant development that warrant a change in public health strategy, WHO will promptly alert Member States and the public. XBB*XBB* is a recombinant of BA.2.10.1 and BA.2.75 sublineages. As of epidemiological week 40 (3 to 9 October), from the sequences submitted to GISAID, XBB* has a global prevalence of 1.3% and it has been detected in 35 countries. The TAG-VE discussed the available data on the growth advantage of this sublineage, and some early evidence on clinical severity and reinfection risk from Singapore and India, as well as inputs from other countries. There has been a broad increase in prevalence of XBB* in regional genomic surveillance, but it has not yet been consistently associated with an increase in new infections. While further studies are needed, the current data do not suggest there are substantial differences in disease severity for XBB* infections. There is, however, early evidence pointing at a higher reinfection risk, as compared to other circulating Omicron sublineages. Cases of reinfection were primarily limited to those with initial infection in the pre-Omicron period. As of now, there are no data to support escape from recent immune responses induced by other Omicron lineages. Whether the increased immune escape of XBB* is sufficient to drive new infection waves appears to depend on the regional immune landscape as affected by the size and timing of previous Omicron waves, as well as the COVID-19 vaccination coverage. BQ.1*BQ.1* is a sublineage of BA.5, which carries spike mutations in some key antigenic sites, including K444T and N460K. In addition to these mutations, the sublineage BQ.1.1 carries an additional spike mutation in a key antigenic site (i.e. R346T). As of epidemiological week 40 (3 to 9 October), from the sequences submitted to GISAID, BQ.1* has a prevalence of 6% and it has been detected in 65 countries. While there are no data on severity or immune escape from studies in humans, BQ.1* is showing a significant growth advantage over other circulating Omicron sublineages in many settings, including Europe and the US, and therefore warrants close monitoring. It is likely that these additional mutations have conferred an immune escape advantage over other circulating Omicron sublineages, and therefore a higher reinfection risk is a possibility that needs further investigation. At this time there is no epidemiologic data to suggest an increase in disease severity. The impact of the observed immunological changes on vaccine escape remains to be established. Based on currently available knowledge, protection by vaccines (both the index and the recently introduced bivalent vaccines) against infection may be reduced but no major impact on protection against severe disease is foreseen. Overall summaryThe Omicron variant of concern remains the dominant variant circulating globally, accounting for nearly all sequences reported to GISAID[1]. While we are looking at a vast genetic diversity of Omicron sublineages, they currently display similar clinical outcomes, but with differences in immune escape potential. The potential impact of these variants is strongly influenced by the regional immune landscape. While reinfections have become an increasingly higher proportion of all infections, this is primarily seen in the background of non-Omicron primary infections. With waning immune response from initial waves of Omicron infection, and further evolution of Omicron variants, it is likely that reinfections may rise further. The role of the TAG-VE is to alert WHO if a variant with a substantially different phenotype (e.g. a variant that can cause a more severe disease or lead to large epidemic waves causing increased burden to the healthcare system) is emerging and likely to pose a significant threat. Based on currently available evidence, the TAG-VE does not feel that the overall phenotype of XBB* and BQ.1* diverge sufficiently from each other, or from other Omicron sublineages with additional immune escape mutations, in terms of the necessary public health response, to warrant the designation of a new variant of concern and assignment of a new label, but the situation will be reassessed regularly. We note these two sublineages remain part of Omicron, which is a variant of concern with very high reinfection and vaccination breakthrough potential, and surges in new infections should be handled accordingly. While so far there is no epidemiological evidence that these sublineages will be of substantially greater risk compared to other Omicron sublineages, we note that this assessment is based on data from sentinel nations and may not be fully generalizable to other settings. Wide-ranging, systematic laboratory-based efforts are urgently needed to make such determinations rapidly and with global interpretability. WHO will continue to closely monitor the XBB* and BQ.1* lineages as part of Omicron and requests countries to continue to be vigilant, to monitor and report sequences, as well as to conduct independent and comparative analyses of the different Omicron sublineages. The TAG-VE meets regularly and continues to assess the available data on the transmissibility, clinical severity, and immune escape potential of variants, including the potential impact on diagnostics, therapeutics, and the effectiveness of vaccines in preventing infection and/or severe disease. [1] Weekly epidemiological update on COVID-19 — 26 October 2022 (who.int)

Microbial life may have resided within the first four kilometers of Mars’s porous crust.

Four billion years ago, the solar system was still young. Almost fully formed, its planets were starting to experience asteroid strikes a little less frequently. Our own planet could have become habitable as long as 3.9 billion years ago, but its primitive biosphere was much different than it is today. Life had not yet invented photosynthesis, which some 500 million years later would become its main source of energy. The primordial microbes — the common ancestors to all current life forms on Earth — in our planet’s oceans, therefore, had to survive on another source of energy.


Some of the oldest life forms in our biosphere were microorganisms known as “hydrogenotrophic methanogens” that particularly benefited from the atmospheric composition of the time. Feeding on the CO2 (carbon dioxide) and H2 (dihydrogen) that abounded in the atmosphere (with H2 representing between 0.01 and 0.1% of the atmospheric composition, compared to the current approximate of 0.00005%), they harnessed enough energy to colonize the surface of our planet’s oceans.

In return, they released into the atmosphere large amounts of CH4 (a.k.a., methane, from which they get their name), a potent greenhouse gas that accumulated and heated up the climate. Since our sun at the time was not as bright as it is today, it may not have been able to maintain temperate conditions on the planet’s surface without the intervention of other aspects. As such, thanks to these methanogens, the very emergence of life on Earth may itself have helped ensure our planet’s habitability, setting the right conditions for the evolution and complexification of the terrestrial biosphere for the billions of years that followed.

While this is the likeliest explanation for the early development of habitability on Earth, what was it like for the other planets of the solar system, such as our neighbor, the red planet? As we continue to explore Mars, it is becoming ever clearer that similar environmental conditions were developing on its surface at the same time as those that enabled methanogens to flourish in the oceans back on Earth.

The scientists said their spacetime simulation “agrees very well with theory.”

A team of physicists used a “quantum field simulator” to simulate a tiny expanding universe made out of ultracold atoms, a report from VICE

Simulating spacetime.


Pixelparticle/iStock.

The scientists conducted the experiment to simulate the early rapid expansion of the universe following the Big Bang. Their work could lead to accurate representations of the universe in future experiments, allowing for the testing of countless models of the early evolution of the cosmos.

The observation of the onset of turbulence in a gas of bosons allows researchers to explore how turbulence comes to life.

Despite over a century of trying, physicists have yet to develop a complete theory of turbulence—the complex, chaotic motion of a fluid. Now Maciej Gałka of the University of Cambridge and colleagues have taken a step in that direction by witnessing the onset of turbulence in a quantum gas and observing its evolution over roughly 100 ms [1]. The finding could help scientists answer open questions in turbulence, which is observed in systems ranging from ocean waves to star interiors.

Photograph: Shutterstock

Elon Musk doesn’t follow the same standards that most entrepreneurs do. He’s different, he likes to be different!

And when you’re different, and you’re not afraid to be, it’s okay to test a cigar (or should I say ‘joint’?) of tobacco mixed with marijuana, on Joe Rogan’s famous podcast. But if you look closely, Elon was just nice (polite) and followed Rogan’s elaborate script. Before trying it, Musk even asked him if it was legal.

Then all those facial expressions of Musk, which photojournalists love to catch, go viral as if he’s there promoting some soft drug or passing abroad that his office at Tesla (or SpaceX) is enveloped in a large cloud of smoke.

Quite the opposite. The expressions themselves spoke for themselves, as if to say, “This is nothing special, Joe. Why do you waste my time with these scenes”? Musk even claimed that weed is not good for productivity at all, but it has nothing against (as I do, by the way).

An international research team led by the University of Minnesota Twin Cities has measured the size of a star dating back 2 billion years after the Big Bang, or more than 11 billion years ago. Detailed images show the exploding star cooling and could help scientists learn more about the stars and galaxies present in the early universe. The paper is published in Nature.

“This is the first detailed look at a at a much earlier epoch of the universe’s evolution,” said Patrick Kelly, a lead author of the paper and an associate professor in the University of Minnesota School of Physics and Astronomy. “It’s very exciting because we can learn in detail about an individual star when the universe was less than a fifth of its current age, and begin to understand if the stars that existed many billions of years ago are different from the ones nearby.”

The red supergiant in question was about 500 times larger than the sun, and it’s located at redshift three, which is about 60 times farther away than any other supernova observed in this detail.